CoronaryAtlas logo
CoronaryAtlas
Sphingomyelin Synthase 2
Pathway / Lipid retention & oxidation

Sphingomyelin Synthase 2

SGMS2gene

SGMS2 regulates ceramide and sphingomyelin metabolism, affecting lipoprotein atherogenicity and subendothelial lipid accumulation.

Pathway placement
Cascade stepLipid retention & oxidation
Confidencemedium
RationaleRemodels sphingomyelin and ceramides; dysregulation affects lipoprotein composition and atherogenicity.
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000164023

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable

Literature evidence(1)